메뉴 건너뛰기
Journal of Cardiovascular Pharmacology and Therapeutics
Volumn 10, Issue 2, 2005, Pages 81-83
Atrial fibrillation: The rate or rhythm controversy - Can it be resolved on the basis of clinical trial data?
Author keywords

[No Author keywords available]
Indexed keywords

AMIODARONE; PLACEBO; SOTALOL;
EID: 20544469043     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840501000201     Document Type: Editorial
Times cited : (1)
References (10)
  • 1
    • 0036664607 scopus 로고    scopus 로고
    • Atrial fibrillation following investigation of rhythm management: AFFIRM Trial Outcomes. What might be their implications for arrhythmia control
    • Singh BN. Atrial fibrillation following investigation of rhythm management: AFFIRM Trial Outcomes. What might be their implications for arrhythmia control. J Cardiovasc Pharmacol Therapeut 7(3):131-133, 2002
    • (2002) J Cardiovasc Pharmacol Therapeut , vol.7 , Issue.3 , pp. 131-133
    • Singh, B.N.1
  • 2
    • 0036797776 scopus 로고    scopus 로고
    • Atrial fibrillation: An old disease, a new epidemic
    • Tsang TS, Gersh BJ. Atrial fibrillation: An old disease, a new epidemic. Am J Med 113:432-35, 2002
    • (2002) Am J Med , vol.113 , pp. 432-435
    • Tsang, T.S.1    Gersh, B.J.2
  • 3
    • 0042315331 scopus 로고    scopus 로고
    • Atrial fibrillation: Epidemiologic considerations and rationale for conversion and maintenance of sinus rhythm
    • Singh BN. Atrial fibrillation: Epidemiologic considerations and rationale for conversion and maintenance of sinus rhythm. J Cardiovasc Pharmacol Therapeut 8(1):S13-S26, 2003
    • (2003) J Cardiovasc Pharmacol Therapeut , vol.8 , Issue.1
    • Singh, B.N.1
  • 4
    • 85046913530 scopus 로고    scopus 로고
    • A comparison of rate control and rhythm control in patients with atrial fibrillation
    • The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:185-193, 2002
    • (2002) N Engl J Med , vol.347 , pp. 185-193
  • 5
    • 85031573929 scopus 로고    scopus 로고
    • Rhythm versus rate control in atrial fibrillation - A randomized trial
    • Hohnloser SH, Kuck KH, Lilienthal J, for the PIAF Investigators. Rhythm versus rate control in atrial fibrillation-a randomized trial. Lancet 356:1789-1794, 2002
    • (2002) Lancet , vol.356 , pp. 1789-1794
    • Hohnloser, S.H.1    Kuck, K.H.2    Lilienthal, J.3
  • 6
    • 0037028033 scopus 로고    scopus 로고
    • A comparison of rate control in patients with recurrent persistent atrial fibrillation
    • Van Gelder IC, Hagens VE, Bosker HA, et al for the Rate Control versus Electrical Control for Persistent Atrial Fibrillation Study Group. A comparison of rate control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834-1840, 2002
    • (2002) N Engl J Med , vol.347 , pp. 1834-1840
    • Van Gelder, I.C.1    Hagens, V.E.2    Bosker, H.A.3
  • 7
    • 17944363568 scopus 로고    scopus 로고
    • Amiodarone versus sotalol for atrial fibrillation
    • Singh BN, Singh SN, Reda DJ. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 352:1861-1872, 2005
    • (2005) N Engl J Med , vol.352 , pp. 1861-1872
    • Singh, B.N.1    Singh, S.N.2    Reda, D.J.3
  • 8
    • 0027172112 scopus 로고
    • Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease
    • Van Gelder IC, Crijns HJ, Blanksma PK, et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol 72:560-566, 1993
    • (1993) Am J Cardiol , vol.72 , pp. 560-566
    • Van Gelder, I.C.1    Crijns, H.J.2    Blanksma, P.K.3
  • 9
    • 0027372627 scopus 로고
    • The effect of cardioversion on exercise capacity in patients with atrial fibrillation
    • Ueshima K, Myers J, Morris CK, et al. The effect of cardioversion on exercise capacity in patients with atrial fibrillation. Am Heart J 126:1021-1024, 1993
    • (1993) Am Heart J , vol.126 , pp. 1021-1024
    • Ueshima, K.1    Myers, J.2    Morris, C.K.3
  • 10
    • 84993949194 scopus 로고    scopus 로고
    • β-adrenergic blockers as antiarrhythmic and antifibrillatory compounds: An overview
    • Singh BN. β-Adrenergic blockers as antiarrhythmic and antifibrillatory compounds: An overview. J Cardiovasc Pharmacol Therapeut 10(2):000-000, 2005
    • (2005) J Cardiovasc Pharmacol Therapeut , vol.10 , Issue.2
    • Singh, B.N.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.